Identification of pyrazolo-pyrimidinones as GHS-R1a antagonists and inverse agonists for the treatment of obesity

MedChemComm ◽  
2013 ◽  
Vol 4 (2) ◽  
pp. 456 ◽  
Author(s):  
William McCoull ◽  
Peter Barton ◽  
Anders Broo ◽  
Alastair J. H. Brown ◽  
David S. Clarke ◽  
...  
Keyword(s):  
Inverse Agonists ◽  
Treatment Of Obesity

1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists for the Treatment of Obesity

2009 ◽  
Vol 52 (8) ◽  
pp. 2550-2558 ◽  
Author(s):  
Petr Vachal ◽  
Joan M. Fletcher ◽  
Tung M. Fong ◽  
Cathy C. R.-R. Huang ◽  
Julie Lao ◽  
...  
Keyword(s):  
Inverse Agonists ◽  
Cannabinoid 1 Receptor ◽  
Treatment Of Obesity

Benzodioxoles: Novel Cannabinoid-1 Receptor Inverse Agonists for the Treatment of Obesity

2008 ◽  
Vol 51 (7) ◽  
pp. 2115-2127 ◽  
Author(s):  
Leo Alig ◽  
Jochem Alsenz ◽  
Mirjana Andjelkovic ◽  
Stefanie Bendels ◽  
Agnès Bénardeau ◽  
...  
Keyword(s):  
Inverse Agonists ◽  
Cannabinoid 1 Receptor ◽  
Treatment Of Obesity

5-Hydroxyindole-2-carboxylic Acid Amides: Novel Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity

2009 ◽  
Vol 52 (13) ◽  
pp. 3855-3868 ◽  
Author(s):  
Pascale David Pierson ◽  
Alec Fettes ◽  
Christian Freichel ◽  
Silvia Gatti-McArthur ◽  
Cornelia Hertel ◽  
...  
Keyword(s):  
Carboxylic Acid ◽  
Inverse Agonists ◽  
Carboxylic Acid Amides ◽  
Treatment Of Obesity

scholarly journals Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity: Validation of the Target and Identification of Novel Series

2009 ◽  
Vol 63 (5) ◽  
pp. 275-278 ◽  
Author(s):  
Pascale David Pierson ◽  
Christian Freichel ◽  
Silvia Gatti-Mac Arthur ◽  
Cornelia Hertel ◽  
Jörg Huwyler ◽  
...  
Keyword(s):  
Inverse Agonists ◽  
Treatment Of Obesity

Functional characterization of human brown adipose tissue metabolism

2020 ◽  
Vol 477 (7) ◽  
pp. 1261-1286 ◽  
Author(s):  
Marie Anne Richard ◽  
Hannah Pallubinsky ◽  
Denis P. Blondin
Keyword(s):  
Adipose Tissue ◽  
Brown Adipose Tissue ◽  
Functional Characterization ◽  
Human Infants ◽  
Positron Emission ◽  
Brown Adipose ◽  
Treatment Of Obesity ◽  
And Function

Brown adipose tissue (BAT) has long been described according to its histological features as a multilocular, lipid-containing tissue, light brown in color, that is also responsive to the cold and found especially in hibernating mammals and human infants. Its presence in both hibernators and human infants, combined with its function as a heat-generating organ, raised many questions about its role in humans. Early characterizations of the tissue in humans focused on its progressive atrophy with age and its apparent importance for cold-exposed workers. However, the use of positron emission tomography (PET) with the glucose tracer [18F]fluorodeoxyglucose ([18F]FDG) made it possible to begin characterizing the possible function of BAT in adult humans, and whether it could play a role in the prevention or treatment of obesity and type 2 diabetes (T2D). This review focuses on the in vivo functional characterization of human BAT, the methodological approaches applied to examine these features and addresses critical gaps that remain in moving the field forward. Specifically, we describe the anatomical and biomolecular features of human BAT, the modalities and applications of non-invasive tools such as PET and magnetic resonance imaging coupled with spectroscopy (MRI/MRS) to study BAT morphology and function in vivo, and finally describe the functional characteristics of human BAT that have only been possible through the development and application of such tools.

The behavioral treatment of obesity.

2001 ◽  
Vol 2 (2) ◽  
pp. 133-140 ◽  
Author(s):  
Drew A. Anderson ◽  
Jennifer R. Shapiro ◽  
Jennifer D. Lundgren
Keyword(s):  
Behavioral Treatment ◽  
Treatment Of Obesity
Sign in / Sign up

Export Citation Format

Share Document